Epithalon (also rendered Epitalon) is a synthetic tetrapeptide with the sequence Ala-Glu-Asp-Gly, representing the active pharmacological fragment of the naturally occurring pineal polypeptide preparation Epithalamin. The sequence was identified and characterized by Vladimir Khavinson and colleagues at the St. Petersburg Institute of Bioregulation and Gerontology, whose work on short peptide bioregulators over several decades established Epithalon as a research tool for the study of telomerase activation, telomere dynamics in somatic cells, and biological aging biomarkers.

From a mechanistic standpoint, Epithalon occupies an unusual niche in aging research: it is among the very few short synthetic peptides for which published laboratory data reports telomerase activation in primary human somatic cells — a finding significant because telomerase activity is typically restricted in differentiated somatic cells but is central to the maintenance of telomere length across cell division cycles. Research groups have studied Epithalon as a probe for understanding the signaling pathways that modulate telomerase expression in non-germline cell populations.

Research Use Reminder: Epithalon is sold exclusively for in-vitro and preclinical laboratory research. It is not approved for therapeutic use by any regulatory authority.

Biochemical Identity & Structural Properties

PropertyValue
Full NameEpithalon / Epitalon / Ala-Glu-Asp-Gly
SequenceH-Ala-Glu-Asp-Gly-OH
Molecular FormulaC₁₄H₂₂N₄O₉
Molecular Weight390.35 g/mol
CAS Number307297-39-8
ClassificationTetrapeptide bioregulator; pineal-derived peptide analog
Biological OriginSynthetic analog of the active fragment of Epithalamin (pineal polypeptide extract)
SolubilityWater-soluble; soluble in PBS or sterile saline
Storage (lyophilized)−20°C, desiccated, protected from light

Proposed Mechanisms of Action

Telomerase Activation in Somatic Cell Models

The most widely cited mechanistic finding in Epithalon research is its documented activation of telomerase in human somatic cell cultures. Khavinson et al. (2003) published data demonstrating that exposure of human fetal fibroblasts to Epithalon was associated with measurable telomerase activity as assessed by TRAP (Telomeric Repeat Amplification Protocol) assay, alongside statistically significant elongation of mean telomere length. This finding is scientifically notable because endogenous telomerase activity is suppressed in most differentiated somatic cells — activation of the catalytic subunit TERT (telomerase reverse transcriptase) represents a primary checkpoint of cellular aging research. Research has examined Epithalon as a tool for studying what signals can upregulate TERT expression outside of germline and cancer cell contexts.

Pineal Axis and Melatonin Pathway Research

Epithalon's parent compound, Epithalamin, was characterized in the context of pineal gland function research. Studies have examined the relationship between short peptide bioregulators derived from pineal tissue and the regulation of melatonin synthesis — specifically the activity of the rate-limiting enzyme N-acetyltransferase (AANAT) in the melatonin biosynthesis pathway. Research has documented that Epithalamin preparations modulate pinealocyte function in animal models, and subsequent work on Epithalon has attempted to isolate the active tetrapeptide's contribution to these effects.

Epigenetic Chromatin Remodeling Research

Short peptide bioregulators of the Khavinson series have been studied for their interactions with histone complexes and potential for influencing chromatin compaction. In vitro studies have examined Epithalon's capacity to interact with histones H1 and H2B in nuclear preparations, suggesting a potential mechanism by which this small peptide might influence gene expression programs related to the epigenetic landscape of aging cells. This line of research positions Epithalon within a broader interest in peptide-based chromatin regulators as probes for aging biology.

Summary of Published Research Findings

Important Context: The majority of Epithalon research originates from a single primary research group (Khavinson et al., St. Petersburg). Independent replication of key findings — particularly the telomerase activation data — in other laboratories and model systems represents an active area of scientific interest. All summaries presented here reflect published literature at the time of writing and are for educational and laboratory research context only.

Key Published References

Khavinson VKh, Bondarev IE, Butyugov AA. (2003). Epithalon peptide induces telomerase activity and telomere elongation in human somatic cells. Bulletin of Experimental Biology and Medicine, 135(6), 590–592. PMID: 12949764

Anisimov VN, Khavinson VKh, Popovich IG, et al. (2003). Effect of Epitalon on biomarkers of aging, life span and spontaneous tumor incidence in female Swiss-derived SHR mice. Biogerontology, 4(4), 193–202. PMID: 12833000

Khavinson VKh, Shataeva LK, Kukanova AV. (2006). [Interaction of Glu-Asp-Gly tripeptide with nucleohistone]. Biofizika, 51(3), 509–514. PMID: 16808228

Storage & Laboratory Handling